These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11053590)

  • 21. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt.
    Talaat M; Kandeel A; El-Shoubary W; Bodenschatz C; Khairy I; Oun S; Mahoney FJ
    Am J Infect Control; 2003 Dec; 31(8):469-74. PubMed ID: 14647109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1999 facility Profile Reports.
    Armistead N; Mays C
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S31-5. PubMed ID: 11053584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved immunogenicity of a novel third-generation recombinant hepatitis B vaccine in patients with end-stage renal disease.
    Weinstein T; Chagnac A; Boaz M; Ori Y; Herman M; Zevin D; Schmilovitz-Weiss H; Gafter U
    Nephron Clin Pract; 2004; 97(2):c67-72. PubMed ID: 15218332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.
    Berns JS; Fishbane S; Elzein H; Lynn RI; Deoreo PB; Tharpe DL; Meisels IS
    Hemodial Int; 2005 Jul; 9(3):255-63. PubMed ID: 16191075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Our peritonitis continuous quality improvement project: where there is a will there is a way.
    Nasso L
    CANNT J; 2006; 16(1):20-3. PubMed ID: 16615702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B and C in dialysis units in Iran: changing the epidemiology.
    Alavian SM; Bagheri-Lankarani K; Mahdavi-Mazdeh M; Nourozi S
    Hemodial Int; 2008 Jul; 12(3):378-82. PubMed ID: 18638096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccination in correctional health care workers.
    Gershon RR; Mitchell C; Sherman MF; Vlahov D; Lears MK; Felknor S; Lubelczyk RA
    Am J Infect Control; 2005 Nov; 33(9):510-8. PubMed ID: 16260326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vaccination scheme in advanced chronic kidney disease].
    Barril G; Teruel JL
    Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in dialysis units' quality improvement practices from 1994 to 1996.
    Frederick PR; Frankenfield DL; Biddle MG; Sims TW
    ANNA J; 1998 Oct; 25(5):469-78. PubMed ID: 9887699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a quality improvement program in acute care evaluated by patients, nurses, and physicians.
    Hansson E; Fridlund B; Hallström I
    Pain Manag Nurs; 2006 Sep; 7(3):93-108. PubMed ID: 16931415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing the trend: a prospective study on factors contributing to the growth rate of peritoneal dialysis programs.
    Gadallah MF; Ramdeen G; Torres-Rivera C; Ibrahim ME; Myrick S; Andrews G; Quin A; Fang C; Crossman A
    Adv Perit Dial; 2001; 17():122-6. PubMed ID: 11510258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBV infection in patients with end-stage renal disease.
    Fabrizi F; Bunnapradist S; Martin P
    Semin Liver Dis; 2004; 24 Suppl 1():63-70. PubMed ID: 15192803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy.
    Liu JH; Liu YL; Lin HH; Yang YF; Kuo HL; Lin PW; Huang CC
    Int J Clin Pract; 2009 Mar; 63(3):387-93. PubMed ID: 18410348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of hepatitis B and C].
    Lesnikar V
    Acta Med Croatica; 2005; 59(5):383-8. PubMed ID: 16381231
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection in hemodialysis: recent discoveries.
    Fabrizi F; Lunghi G; Martin P
    J Nephrol; 2002; 15(5):463-8. PubMed ID: 12455711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.